Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,136 USD | +1,57 % | +2,72 % | -76,95 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Eric Konofal
FOU | Founder | 57 | 10/06/15 |
Alexander Zwyer
FOU | Founder | 54 | 10/06/15 |
Director of Finance/CFO | - | 20/05/23 | |
George Apostol
CTO | Chief Tech/Sci/R&D Officer | 51 | 08/09/22 |
David Moskowitz
IRC | Investor Relations Contact | - | - |
Hervé Girsault
PRN | Corporate Officer/Principal | 64 | 01/09/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Audrey Greenberg
BRD | Director/Board Member | 51 | 30/06/23 |
Alexander Zwyer
FOU | Founder | 54 | 10/06/15 |
Ronald Hafner
FOU | Founder | 60 | 10/06/15 |
Director/Board Member | 55 | 17/06/21 | |
Anthony Walsh
BRD | Director/Board Member | - | 30/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 42 806 136 | 27 083 431 ( 63,27 %) | 3 242 887 ( 7,576 %) | 63,27 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-76,95 % | 6,41 M | |
+26,28 % | 48,09 mil M | |
-3,99 % | 40,43 mil M | |
+46,85 % | 40,62 mil M | |
-6,20 % | 28,36 mil M | |
+6,36 % | 24,89 mil M | |
-21,47 % | 19,01 mil M | |
+27,58 % | 12,09 mil M | |
-2,75 % | 11,8 mil M | |
-2,02 % | 11,88 mil M |
- Bolsa de valores
- Acciones
- Acción NLSP
- Empresa NLS Pharmaceutics Ltd.